Griffin Asset Management's Latest 13F Holdings: Winners and Losers of Q4 2022
Ava Hoppe | 5 May, 2023
Griffin Asset Management has released its latest 13F filings, revealing the fund's holdings for Q4 2022. The report showcases movements in the top holdings, sectors that gained and lost in the quarter and how the fund managers played the market.
Apple Inc remained a top holding for Griffin Asset Management, with a slight increase in shares but a decrease in value. Microsoft Corp followed closely behind, with an increase in shares and value.
The pharmaceutical sector saw significant changes in holdings. AbbVie Inc experienced a 24% increase in shares and a substantial increase in value, while Merck & Co saw a decrease in shares but still managed a 23.3% increase in value.
The retail sector was also a mixed bag for Griffin Asset Management. While TJX Cos recorded a 28% increase in value, Home Depot Inc only saw a 17% increase.
Energy stocks Chevron Corp and Exxon Mobil Corp performed well, with a 25% and 27% increase in value, respectively. ConocoPhillips also managed a 15% increase in value.
The financial sector was a mixed bag for Griffin Asset Management. While Wells Fargo Co saw a modest 2.7% increase in value, American Express Co recorded a 14.8% increase, and Bank of America Corp managed a 13.2% increase.
One of the biggest losers in the quarter was Amazon.com Inc, which saw a significant decrease in value of 33.7%. Other notable losers included Walt Disney Co (-12.4%), Goldman Sachs Group Inc (-10.8%), and Alphabet Inc (-20.6%).
Griffin Asset Management also made some intriguing moves within the quarter. They increased their holdings in Accelerate Diagnostics Inc by 45.5%, while trimming their shares in Qualcomm Inc (-2.9%) and The Trade Desk Inc (-7.6%).
In conclusion, Griffin Asset Management's latest 13F filings indicate a cautiously optimistic approach to the market with a focus on healthcare and energy stocks, whilst trimming shares in a few big tech companies. Time will tell how their strategy pans out in the coming months.
Other Posts
- Betterment LLC Q3 2022 vs. Q4 2022 13F Holdings Comparison: A Look at the Changes in Fund Holdings
- Ceredex Value Advisors LLC Q2 2023 vs. Q3 2023: A Detailed Analysis of 13F Holdings Changes
- Pacer Advisors, Inc.'s Q3 2022 vs. Q4 2022 13F Holdings Comparison: Analysis of Top Holdings and Changes in Value
- Foundry Partners, LLC Q1 2023 vs. Q2 2023 13F Holdings Comparison
- Exploring the Winds of Change: How Bourne Lent Asset Management Inc Adjusted its Portfolio in Early 2024
- PFG Advisors Q1 2023 vs. Q2 2023 13F Holdings Comparison
- Investment Counsel Inc. Q4 2020 vs. Q1 2021: A Deep Dive into 13F Holdings Comparison
- Blue Chip Wealth Management, Inc. Q2 2020 vs. Q3 2020: A Look at Top Holdings
- Anne Arundel Dermatology Names Vincent Bradley as Chief Executive Officer
- Examining ACON Equity Management's Q3 vs. Q4 2022 Holdings: Notable Changes in Funko, Codexis, and Bluebird Bio Shares.